Alison Birtle
- Surgery top 2%
- Pulmonary and Respiratory Medicine top 2%
- Oncology top 5%
- Urology top 1%
- Molecular Biology
- Co-authors
- Robert HuddartEmma HallRebecca LewisJenny DonovanRobert J. JonesSangeetha ParamasivanMatthew R. SydesNicholas D. James
- Topics
- Prostate Cancer Treatment and Research (58 papers)Bladder and Urothelial Cancer Treatments (41 papers)Radiopharmaceutical Chemistry and Applications (24 papers)
- Partner nations
- United KingdomFranceUnited States
In The Last Decade
Alison Birtle
112 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 118
- Surgery 1.2k
- Pulmonary and Respiratory Medicine 931
- Oncology 571
- Urology 357
- Molecular Biology 290
Countries citing papers authored by Alison Birtle
This map shows the geographic impact of Alison Birtle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alison Birtle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alison Birtle more than expected).
Fields of papers citing papers by Alison Birtle
This network shows the impact of papers produced by Alison Birtle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alison Birtle. The network helps show where Alison Birtle may publish in the future.
Co-authorship network of co-authors of Alison Birtle
This figure shows the co-authorship network connecting the top 25 collaborators of Alison Birtle. A scholar is included among the top collaborators of Alison Birtle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alison Birtle. Alison Birtle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (TaT1 and Carcinoma In Situ)—A Summary of the 2024 Guidelines Updatebreakdown → | 54 |
| 3 | 0 | |
| 4 | 12 | |
| 5 | European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2023 Updatebreakdown → | 239 |
| 6 | Addition of nintedanib or placebo to neoadjuvant gemcitabine and cisplatin in locally advanced muscle-invasive bladder cancer (NEOBLADE): a double-blind, randomised, phase 2 trial | 20 |
| 7 | 17 | |
| 8 | 14 | |
| 9 | 6 | |
| 10 | 2 | |
| 11 | 51 | |
| 12 | 7 | |
| 13 | 15 | |
| 14 | 73 | |
| 15 | 2 | |
| 16 | 27 | |
| 17 | 1 | |
| 18 | 35 | |
| 19 | 25 | |
| 20 | 15 |
About Alison Birtle
Alison Birtle is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Urology, having authored 117 papers that have together received 2.4k indexed citations. Recurring topics across this work include Prostate Cancer Treatment and Research (58 papers), Bladder and Urothelial Cancer Treatments (41 papers) and Radiopharmaceutical Chemistry and Applications (24 papers). The work is most often cited by research in Urology (357 citations), Pulmonary and Respiratory Medicine (931 citations) and Surgery (1.2k citations). Alison Birtle has collaborated with scholars based in United Kingdom, France and United States. Frequent co-authors include Robert Huddart, Emma Hall, Rebecca Lewis, Jenny Donovan, Robert J. Jones, Sangeetha Paramasivan, Matthew R. Sydes, Nicholas D. James, Amit Bahl and Simon Chowdhury. Their work appears in journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.